These findings are potentially important clinically, given that ZNF281 has been implicated in several cancers and high expression of ZNF281 correlates with significantly poorer outcome in patients across at least 10 different cancer types (Hou et al., 2023). The gene discussed is ZNF281; the disease is cancer.